6. Neonatal Glandulars

Biotics Research realized the importance of neonatal calf serum went beyond the culturing of lymphocytes. From our genetic toxicology work, we knew that neonatal tissues contained fetal growth factors that could keep normal adult cells alive in culture form. We also knew that European doctors, in efforts to restore health in humans, used "live cell therapy", utilizing injections of fetal (almost neonatal) tissues from animals. We knew that glandular products were becoming increasingly popular with some health care professionals in the United States. Histological analysis of neonatal and adult glandular tissues documented the cleanliness and vibrant growth state of neonatal glandular tissues compared to normal, healthy adult gland tissue. Clearly, glandular products from neonatal bovine tissues represented a distinct improvement in quality, as compared with other products available.

The process of Cryosolvation was developed at Biotics Research Corporation to preserve the attributes of neonatal glands and organs, resulting in materials suitable for solid dose production.

Because neonatal glands were relatively fat free, harsh de-fatting procedures used by others in our industry were not necessary. Instead, modest amounts of a mild organic solvent found in our bodies are used to remove fats that could later oxidize and result in short shelf life. Important compounds, like phospholipids, are not removed by this process. Additionally, low temperature drying preserves enzyme activities and conformation of the numerous metabolic intermediate compounds found in neonatal glands. The results are stable materials suitable for delivery in solid dose form, which preserves the essential qualities of neonatal glands.